Analysis of a direct access testing system for the detection of SARS-CoV-2 in the paediatric population attending school
Keywords:
SARS-CoV-2, children, testing system, nasopharyngeal swabAbstract
Background. During the COVID-19 pandemic, the paediatric population plays a minor role in the spread of the SARS-CoV-2 virus. However, in order to keep schools open and reduce SARS-CoV spreading, it is necessary to identify and isolate early SARS-CoV-2 positive paediatric patients even if they are asymptomatic. The aim of this study was to describe a setting for SARS-CoV 2 testing based on the spontaneous presentation of paediatric patients attending school without a medical prescription and explore its appropriateness.
Study design. Cross-sectional study.
Methods. The study performed between September 2020 and March 2021 among a sample of 13,283 paediatric patients who underwent a swab in four different hospital settings (school hot spot, emergency department, day hospital setting and hospital wards). For each patients we collected: date of swab execution, type of swab, execution setting of the swab, result of the swab, information about community spread of the virus in the 14 days prior to the swab execution, sex and age.
Results. In our sample, females accounted for 45.8%. The median age was 6.8 years (IQR 3.0-11.2) and the most frequent age category was between 6 and 11 years (27.9%).
At multivariable models with a swab tested positive as outcome. The swabs executed in all the hospital settings had a lower likelihood of resulting positive compared with the school hot spot setting. Compared with adolescents aged between 14 and 19 years old, new-borns below 3 months (adjOR 1.83, 95% C.I. 1.14-3) and patients aged between 11 and 14 years old (adjOR 1.32, 95% C.I. 1.07-1.63) reported a higher probability of a swab tested positive. Instead, children aged between 3 months and 3 years (adjOR 0.77, 95% C.I. 0.61-0.96) and children aged between 3 years and 6 years (adjOR 0.66, 95% C.I. 0.53-0.83) were less likely to result positive. The higher was the mean of pooled Rt in the 14 days preceding the swab, the higher was the likelihood of resulting positive (adjOR 1.75, 95% C.I. 1.53-1.99).
Conclusion. In conclusion, we found a high incidence of paediatric patients positive to the test for the detection of SARS-CoV-2 at the school hot spot compared with other settings during the period of observation. The free access modality to the nasopharyngeal swab was effective in identifying patients with COVID-19. Public health authorities should implement these testing modality in order to help reduce the spread of SARS-CoV-2 in school settings.
References
1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20; 382(8): 72733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
2. Costantino C, Cannizzaro E, Alba D, Conforto A, Cimino L, Mazzuco W. Sars-Cov-2 pandemic in the mediterranean area: epidemiology and perspectives. EuroMediterranean Biomed J.
2020; 15(25): 102-6. doi: 10.3269/1970-5492
.2020.15.25
3. WHO Coronavirus (COVID-19) Dashboard.
Latest update: 31 January 2023. Available from: https://covid19.who.int/
4. European Centre for Disease Prevention and Control (ECDC). SARS-CoV-2 in children (latest update 14 June 2022). Available from: https:// www.ecdc.europa.eu/en/infectious-diseasetopics/z-disease-list/covid-19/latest-evidence/ sars-cov-2-children
5. Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.World J Pediatr. 2020 Jun; 16(3): 240-46. doi: 10.1007/s12519-020-00345-5. Epub 2020 Feb 5.
6. European Center for Disease Prevention and Control (ECDC). COVID-19 in children and the role of school settings in COVID-19 transmission. Stockholm: ECDC; 2020.
7. Epicentro. Istituto Superiore di Sanità (ISS). Sorveglianza integrata COVID-19: i principali dati nazionali. 2021.
8. Bellino S, Rota MC, Riccardo F, et al. Pediatric COVID-19 Cases Prelockdown and Postlockdown in Italy. Pediatrics. 2021 Feb; 147(2): e2020035238. doi: 10.1542/peds.2020-035238. Epub 2020 Nov 5.
9. Swiss National COVID-19 Science Task Force. The role of children (≤12 years of age) and adolescents (13-17 years of age) in the SARS-CoV-2 pandemic: A rapid review Questions. 2021.
10. Gaythorpe KAM, Bhatia S, Mangal T, et al. Children’s role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility. Publisher Correction: Sci Rep. 2021 Sep 16; 11(1): 18814. doi: 10.1038/s41598-021-97183-w. Erratum for: Sci Rep. 2021 Jul 6; 11(1): 13903.
11. European Centre for Disease Prevention and Control (ECDC). COVID-19 associated with SARS-CoV-2 Multi-country (World). Stockholm: ECDC; 2020.
12. European Centre for Disease Prevention and Control (ECDC). COVID-19 testing strategies and objectives Key messages. Stockholm: ECDC; 2020.
13. Duysburgh ELS, Callies M, Kabouke I, et al. Prevalence and incidence of antibodies against sars-cov-2 in children and school staff mea-
sured between December 2020 and June 2021: an observational sero-prevalence prospective cohort study. Brussels: Sciensano; March 2021: -28.
14. Lo Moro G, Sinigaglia T, Bert F, Savatteri A, Gualano MR, Siliquini R. Reopening Schools during the COVID-19 Pandemic: Overview and Rapid Systematic Review of Guidelines and Recommendations on Preventive Measures and the Management of Cases. Int J Environ Res Public Health. 2020 Nov 27; 17(23): 8839. doi: 10.3390/ijerph17238839.
15. Working Group ISS, Ministero della Salute, Ministero dell’Istruzione, INAIL, Fondazione Bruno Kessler, [Regione Emilia-Romagna, Regione Veneto. Operational guidance for the management of SARS-CoV-2 cases and outbreak in schools and kindergartens. Version of August 28, 2020]. Indicazioni operative per la gestione di casi e focolai di SARS-CoV-2 nelle scuole e nei servizi educativi dell’infanzia. Istituto Superiore di Sanità; 2020: 1-28 (Rapporto ISS COVID-19 n. 58/2020 Rev).
16. Bert F, Thomas R, Lo Moro G, et al. A new strategy to promote flu vaccination among health care workers: Molinette Hospital’s experience. J Eval Clin Pract. 2020 Aug; 26(4): 1205-11. doi: 10.1111/jep.13295. Epub 2019 Nov 7.
17. Città della Salute e della Scienza di Torino. A.O.U. Citta della Salute e della Scienza di Torino - Presentazione Regina Margherita. 2021.
18. World Health Organization (WHO). WHO Guidance Note. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases interim guidance. World Health Organization; 11 Spetember 2020.
19. Cui X, Zhao Z, Zhang T, et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol. 2021 Feb; 93(2): 1057-69. doi:10.1002/ jmv.26398. Epub 2020 Sep 28.
20. European Centre for Disease Prevention and Control (ECDC). Contact tracing : P ublic health management of persons, including healthcare workers , having had contact with COVID-19 cases in the European Union Target audience Definition of contact persons Healthcare workers Contact management steps after a case is. ECDC Bull. 2020: 7-10.
21. European Centre for Disease Prevention and
Control (ECDC). Contact tracing for COVID19 : current evidence options for scale-up and an assessment of resources needed. ECDC Tech Rep. 2020: 1-9.
22. Adeyinka A, Bailey K, Pierre L, Kondamudi N. COVID 19 infection: Pediatric perspectives. J Am Coll Emerg Physicians Open. 2021 Jan 29; 2(1): e12375. doi: 10.1002/emp2.12375.
23. Cori A, Ferguson NM, Fraser C, Cauchemez S. A new framework and software to estimate timevarying reproduction numbers during epidemics. Am J Epidemiol. 2013 Nov 1; 178(9): 1505-12.
doi: 10.1093/aje/kwt133. Epub 2013 Sep 15.
24. Alimohamadi Y, Taghdir M, Sepandi M. Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Metaanalysis. J Prev Med Public Health. 2020 May; 53(3): 151-7. doi: 10.3961/jpmph.20.076. Epub 2020 Mar 20.
25. Breban R, Vardavas R, Blower S. Theory versus data: how to calculate R0?. PLoS One.
2007 Mar 14; 2(3): e282. doi: 10.1371/journal.
pone.0000282.
26. Ministero della Salute. Nuovo coronavirus. 2021.
27. Kuttiatt VS, Abraham PR, Menon RP, Vaidya PC, Rahi M. Coronavirus disease 2019 in children: Clinical & epidemiological implications. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2): 21-40 10.4103/ijmr.IJMR_977_20.
28. Willeit P, Krause R, Lamprecht B, et al. Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study. Lancet Reg Health Eur. 2021 Jun; 5: 100086. doi: 10.1016/j.lanepe.2021.100086. Epub 2021 Mar 23.
29. Riley S, Walters CE, Wang H, et al. REACT-1 round 7 updated report: regional heterogeneity in changes in prevalence of SARS-CoV-2 infection during the second national COVID-19 lockdown in England. medRxiv 2020 Dec 16. preprint doi:
https://doi.org/10.1101/2020.12.15.20248244.
30. Riley S, Wang H, Eales O, et al. REACT-1 round 9 final report: Continued but slowing decline of prevalence of SARS-CoV-2 during national lockdown in England in February 2021. medRxiv 2021 Mar 6. preprint doi: https://doi.org /10.1101/2021.03.03.21252856.
31. Fragkou PC, Moschopoulos CD, Dimopoulou D, et al. Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis [published online ahead of print, 2022 Nov 3]. Clin Micro-
biol Infect. 2022;S1198-743X(22)00542-0. doi:10.1016/j.cmi.2022.10.028
32. Decreto del Presidente della Giunta Regionale 23 dicembre 2021, n. 100. Disposizioni attuative per la prevenzione e gestione dell’emergenza epidemiologica da COVID-19. Ordinanza ai sensi dell’art. 32, comma 3, della legge 23 dicembre 1978, n. 833, in materia di igiene e sanità pubblica. Misure urgenti per contrastare l’incremento della diffusione del contagio. Regione Piemonte BU51S4 23/12/2021.
33. European Centre for Disease Control (ECDC). COVID-19 in children and the role of school settings in COVID-19 transmission. Stockholm: ECDC; 2020.
34. Viner RM, Mytton OT, Bonell C, et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2021 Feb 1; 175(2): 143-56. doi: 10.1001/jamapediatrics.2020.4573. Erratum in: JAMA Pediatr. 2021 Feb 1; 175(2): 212.
35. European Centre for Disease Prevention and Control (ECDC). Objectives for COVID-19 testing in school settings - first update. Stockholm: ECDC; 21 August 2020: 19-22.
36. World Health Organization (WHO). Tracking SARS-CoV-2 Variants. World Health Organization; 4 Dec 2021: 1-13. Available on: https:// www.who.int/en/activities/tracking-SARS-CoV2-variants/ [Last accessed: 2022 Aug 8].
37. Xia F, Yang X, Cheke RA, Xiao Y. Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout. Infect Dis Model. 2021; 6: 988-96. doi:10.1016/j.idm.2021.08.001. Epub 2021 Aug 8.
38. European Centre for Disease Prevention and Control (ECDC). Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update. Stokholm: ECDC; 10 June 2021.
39. European Centre for Disease Prevention and Control (ECDC). SARS-CoV-2 variants of concern as of 26 January 2023. Available on: https://www.ecdc.europa.eu/en/covid-19/ variants-concern.
40. Kenney PO, Chang AJ, Krabill L, Hicar MD. Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave. Viruses. 2023 Jan 7; 15(1): 180. doi:10.3390/v15010180
41. Al-Hosani F, Al-Mazrouei S, Al-Memari S, Al-Yafei Z, Paulo MS, Koornneef E. A Review of COVID-19 Mass Testing in the United Arab Emirates. Front Public Health. 2021 May 12; 9: 661134. doi: 10.3389/fpubh.2021.661134.
42. Irfan O, Li J, Tang K, Wang Z, Bhutta ZA. Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis. J Glob Health. 2021 Jul 17; 11: 05013. doi: 10.7189/ jogh.11.05013.
43. Yoon Y, Kim KR, Park H, Kim S, Kim YJ. Stepwise School Opening and an Impact on the Epidemiology of COVID-19 in the Children. J Korean Med Sci. 2020 Nov 30; 35(46): e414. doi: 10.3346/jkms.2020.35.e414.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.